The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases - Fig 1

(A) Overall survival and (B) cumulative incidence of renal cell carcinoma (RCC)-specific mortality in patients with metastatic RCC at diagnosis based on treatment received in full samples. NS = no surgery therapy; CN = cytoreductive nephrectomy.